SynthesisFrontiers in nutrition2025
Mapping the evolution of botanical interventions for diabetic neuropathy: a two-database bibliometric landscape from 2005 to mid-2025.
Synthesis in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study conducts a comprehensive bibliometric analysis to map the evolutionary trajectory, identify research hotspots, and forecast future trends in botanical interventions for diabetic neuropathy (DN) from 2005 to mid-2025. Methods: We retrieved relevant publications from the Web of Science Core Collection and PubMed (2005 to mid-2025). After applying inclusion criteria and removing duplicates, 414 articles and reviews were analyzed using VOSviewer, CiteSpace and Bibliometrix to visualize publication trends, collaboration networks, and keyword dynamics. Results: Annual publication output exhibited exponential growth after 2020, peaking at 71 publications in 2024. China dominated the research output, followed by India and the USA, though international collaboration remained limited. Keyword analysis identified four major research hotpots: molecular mechanisms (e.g., oxidative stress, NF-κB), clinical translation, systems pharmacology of traditional Chinese medicine (TCM), and signaling pathways. Burst detection revealed "network pharmacology" and "TCM" as the current research frontiers. Conclusion: Research on botanical interventions for DN is rapidly expanding, with a clear shift toward mechanistic and computational approaches. Future efforts should prioritize robust clinical trials, international cooperation, and deeper mechanistic studies to translate botanical potential into evidence-based therapies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.